Regorafenib Plus 5-Fluorouracil/Leucovorin Beyond Progression in mCRC
Clinical trial NCT03099486 · TERMINATED
Trial details
- NCT number
- NCT03099486
- Sponsor
- Fox Chase Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-06
- Primary completion
- 2020-06-02
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.